Cargando…

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: A case series

Mostrar otras versiones (1)

BACKGROUND: Mechanically ventilated patients with coronavirus disease 2019 (COVID-19) have a mortality of 24–53%, in part due to distal mucopurulent secretions interfering with ventilation. Dornase alfa is recombinant human DNase 1 and digests DNA in mucoid sputum. Nebulized dornase alfa is FDA-appr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Weber, Andrew G., Chau, Alice S., Egeblad, Mikala, Barnes, Betsy J., Janowitz, Tobias
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273282/ https://www.ncbi.nlm.nih.gov/pubmed/32511514 http://dx.doi.org/10.1101/2020.05.13.20087734

Ejemplares similares

Nebulized in-line endotracheal dornase alfa and albuterol administered to mechanically ventilated COVID-19 patients: a case series
por: Weber, Andrew G., et al.
Publicado: (2020)

Aerosol Delivery of Dornase Alfa Generated by Jet and Mesh Nebulizers
por: Chang, Kyung Hwa, et al.
Publicado: (2020)

The use of dornase alfa in patients with COVID-19
por: Ramachandram, Dinesh Sangarran, et al.
Publicado: (2023)

Comparison of Nebulized Epinephrine to Albuterol in Bronchiolitis
por: Walsh, Paul, et al.
Publicado: (2008)

The effects of ventilator settings, nebulizer and exhalation port positions on albuterol delivery during noninvasive ventilation: an in vitro study
por: Sutherasan, Y, et al.
Publicado: (2015)

Physicochemical compatibility of fluticasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions
por: Kamin, Wolfgang, et al.
Publicado: (2007)

Effects of ventilator settings, nebulizer and exhalation port position on albuterol delivery during non-invasive ventilation: an in-vitro study
por: Sutherasan, Yuda, et al.
Publicado: (2017)

Bronchoscopy for foreign body aspiration and effects of nebulized albuterol and budesonide combination
por: Akcora, Bulent, et al.
Publicado: (2017)

Consideration of dornase alfa for the treatment of severe COVID-19 acute respiratory distress syndrome
por: Earhart, A.P., et al.
Publicado: (2020)

The Use of Dornase Alfa in the Management of COVID-19-Associated Adult Respiratory Distress Syndrome
por: Toma, Andrew, et al.
Publicado: (2021)

Dornase alfa in Cystic Fibrosis: indications, comparative studies and effects on lung clearance index
por: Terlizzi, Vito, et al.
Publicado: (2022)

Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series
por: Terlizzi, Vito, et al.
Publicado: (2022)

Computerized acoustic assessment of treatment efficacy of nebulized epinephrine and albuterol in RSV bronchiolitis
por: Beck, Raphael, et al.
Publicado: (2007)

Preliminary report of in vitro and in vivo effectiveness of dornase alfa on SARS-CoV-2 infection
por: Okur, H.K., et al.
Publicado: (2020)

Non-Randomized Trial of Dornase Alfa for Acute Respiratory Distress Syndrome Secondary to Covid-19
por: Holliday, Zachary M., et al.
Publicado: (2021)

Lactic acidosis and diastolic hypotension after intermittent albuterol nebulization in a pediatric patient
por: Saadia, Tehila A., et al.
Publicado: (2015)

Effect of nebulized eucalyptus on contamination of microbial plaque of endotracheal tube in ventilated patients
por: Amini, Nazanin, et al.
Publicado: (2016)

Use of dornase alfa in the paediatric intensive care unit: current literature and a national cross-sectional survey
por: den Hollander, Bibiche, et al.
Publicado: (2022)

Droplet Size and Distribution of Nebulized 3% Sodium Chloride, Albuterol, and Epoprostenol by Phase Doppler Particle Analyzer
por: McDermott, Kelly, et al.
Publicado: (2021)

Intrapleural Tissue Plasminogen Activator and Dornase Alfa Administration for a Multiloculated Recurrent Malignant Pleural Effusion: A Case Report
por: Nikoomanesh, Kia, et al.
Publicado: (2022)

Protocol for TRAUMADORNASE: a prospective, randomized, multicentre, double-blinded, placebo-controlled clinical trial of aerosolized dornase alfa to reduce the incidence of moderate-to-severe hypoxaemia in ventilated trauma patients
por: Pottecher, Julien, et al.
Publicado: (2020)

A first-year dornase alfa treatment impact on clinical parameters of patients with cystic fibrosis: the Brazilian cystic fibrosis multicenter study
por: Rozov, Tatiana, et al.
Publicado: (2013)

Dornase alpha use in patients with cystic fibrosis
por: Marostica, Paulo José C.
Publicado: (2013)

Response to first dose of inhaled albuterol in mechanically ventilated preterm infants
por: Raffay, Thomas M., et al.
Publicado: (2021)

High-dose versus low-dose nebulized albuterol in acute asthmatic attack: a randomized double-blind clinical trial
por: Hosseinnezhad, A, et al.
Publicado: (2005)

In Vitro Characterization of Aerosolized Albuterol Generated by a Jet Nebulizer and Delivered through a Heated Flow Nasal Cannula System
por: Berlinski, Ariel, et al.
Publicado: (2022)

Clinical efficacy and bleeding outcomes of tissue plasminogen activator and dornase alfa in pleural space infection with once daily concurrent administration: a retrospective cohort study
por: Jiang, Chuan, et al.
Publicado: (2020)

Nebulized albuterol delivery is associated with decreased skeletal muscle strength in comparison with metered‐dose inhaler delivery among children with acute asthma exacerbations
por: Burger, Catherine, et al.
Publicado: (2021)

Significant Lactic Acidosis from Albuterol
por: Hockstein, Maxwell, et al.
Publicado: (2018)

Subcutaneous terbutaline as an alternative to aerosolized albuterol
por: Strauss, Ronald A.
Publicado: (2020)

Nebulised dornase alfa versus placebo or hypertonic saline in adult critically ill patients: a systematic review of randomised clinical trials with meta-analysis and trial sequential analysis
por: Claudius, Casper, et al.
Publicado: (2015)

Efficacy and safety of ipratropium bromide/albuterol compared with albuterol in patients with moderate-to-severe asthma: a randomized controlled trial
por: Donohue, James F., et al.
Publicado: (2016)

USE OF ALTEPLASE AND DORNASE FOR LYSIS OF COVID-19-RELATED LOCULATED PLEURAL EFFUSION
por: STAIANO, PETER P, et al.
Publicado: (2022)

The Effects of Inhaled Albuterol in Transient Tachypnea of the Newborn
por: Kim, Myo-Jing, et al.
Publicado: (2014)

Reply to “Subcutaneous terbutaline as an alternative to aerosolized albuterol”
por: Shaker, Marcus S., et al.
Publicado: (2020)

Caught in the act: revealing the metastatic process by live imaging
por: Fein, Miriam R., et al.
Publicado: (2013)

Budesonide Nebulization in the Treatment of Neonatal Ventilator Associated Pneumonia
por: Li, Baoqiang, et al.
Publicado: (2017)

Isolation of mouse mammary carcinoma-derived macrophages and cancer cells for co-culture assays
por: Sun, Lijuan, et al.
Publicado: (2022)

Paradoxical bronchospasm from benzalkonium chloride (BAC) preservative in albuterol nebulizer solution in a patient with acute severe asthma. A case report and literature review of airway effects of BAC
por: George, Mathew, et al.
Publicado: (2017)

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
por: Nakasone, Elizabeth S., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ec7c9ohjdlp4fcoqoa851u5d3a